Robert J. Hunkler

2.7k total citations · 2 hit papers
31 papers, 1.8k citations indexed

About

Robert J. Hunkler is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Applied Microbiology and Biotechnology. According to data from OpenAlex, Robert J. Hunkler has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Applied Microbiology and Biotechnology. Recurrent topics in Robert J. Hunkler's work include Pharmaceutical Economics and Policy (20 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Pharmaceutical studies and practices (9 papers). Robert J. Hunkler is often cited by papers focused on Pharmaceutical Economics and Policy (20 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Pharmaceutical studies and practices (9 papers). Robert J. Hunkler collaborates with scholars based in United States, Canada and United Kingdom. Robert J. Hunkler's co-authors include Katie J. Suda, Lauri A. Hicks, Rebecca M. Roberts, Thomas H. Taylor, James M. Hoffman, Glen T. Schumock, Lee C. Vermeulen, Linda M. Matusiak, Stephanie J. Schrag and Monina Bartoces and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and The Annual Review of Pharmacology and Toxicology.

In The Last Decade

Robert J. Hunkler

31 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

US Outpatient Antibiotic Prescribing Variation According to Geography, Patient Population, and Provider Specialty in 2011

2015 435 citations Lauri A. Hicks, Rebecca M. Roberts et al. Clinical Infectious Diseases profile →
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers

2014 345 citations Henry M. Dunnenberger, Kristine R. Crews et al. The Annual Review of Pharmacology and Toxicology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert J. Hunkler United States	23	605	419	373	355	350	31	1.8k
Joyce H. S. You Hong Kong	26	262 0.4×	374 0.9×	489 1.3×	178 0.5×	407 1.2×	121	2.7k
Subish Palaian Nepal	26	423 0.7×	373 0.9×	203 0.5×	391 1.1×	143 0.4×	192	2.2k
Alian A. Alrasheedy Saudi Arabia	23	363 0.6×	426 1.0×	209 0.6×	265 0.7×	120 0.3×	76	1.4k
Hege Salvesen Blix Norway	26	552 0.9×	377 0.9×	476 1.3×	503 1.4×	126 0.4×	91	2.5k
Donald G. Klepser United States	21	248 0.4×	245 0.6×	363 1.0×	156 0.4×	101 0.3×	79	1.5k
Syed Tabish R. Zaidi Australia	28	294 0.5×	236 0.6×	233 0.6×	211 0.6×	62 0.2×	108	2.3k
Michael Dooley Australia	31	203 0.3×	513 1.2×	381 1.0×	480 1.4×	188 0.5×	196	3.6k
Asa Auta United Kingdom	25	343 0.6×	173 0.4×	370 1.0×	485 1.4×	46 0.1×	58	1.9k
Peter G. M. Mol Netherlands	25	133 0.2×	443 1.1×	110 0.3×	328 0.9×	178 0.5×	116	1.9k
Amanj Kurdi United Kingdom	26	833 1.4×	242 0.6×	389 1.0×	262 0.7×	33 0.1×	137	1.8k

Countries citing papers authored by Robert J. Hunkler

Since Specialization

Citations

This map shows the geographic impact of Robert J. Hunkler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Hunkler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Hunkler more than expected).

Fields of papers citing papers by Robert J. Hunkler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Hunkler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Hunkler. The network helps show where Robert J. Hunkler may publish in the future.

Co-authorship network of co-authors of Robert J. Hunkler

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Hunkler. A scholar is included among the top collaborators of Robert J. Hunkler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Hunkler. Robert J. Hunkler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tichy, Eric M., Glen T. Schumock, James M. Hoffman, et al.. (2020). National trends in prescription drug expenditures and projections for 2020. American Journal of Health-System Pharmacy. 77(15). 1213–1230. 38 indexed citations

Schumock, Glen T., JoAnn Stubbings, James M. Hoffman, et al.. (2019). National trends in prescription drug expenditures and projections for 2019. American Journal of Health-System Pharmacy. 76(15). 1105–1121. 28 indexed citations

Schumock, Glen T., JoAnn Stubbings, Michelle D. Wiest, et al.. (2018). National trends in prescription drug expenditures and projections for 2018. American Journal of Health-System Pharmacy. 75(14). 1023–1038. 28 indexed citations

Suda, Katie J., Lauri A. Hicks, Rebecca M. Roberts, et al.. (2017). Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010–2015. Clinical Infectious Diseases. 66(2). 185–190. 85 indexed citations

Schumock, Glen T., Edward C. Li, Michelle D. Wiest, et al.. (2017). National trends in prescription drug expenditures and projections for 2017. American Journal of Health-System Pharmacy. 74(15). 1158–1173. 42 indexed citations

Suda, Katie J., et al.. (2016). Spending on Hepatitis C Antivirals in the United States, 2009–2015. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(1). 65–70. 7 indexed citations

Schumock, Glen T., Edward C. Li, Katie J. Suda, et al.. (2016). National trends in prescription drug expenditures and projections for 2016. American Journal of Health-System Pharmacy. 73(14). 1058–1075. 80 indexed citations

Schumock, Glen T., Edward C. Li, Katie J. Suda, et al.. (2015). National trends in prescription drug expenditures and projections for 2015. American Journal of Health-System Pharmacy. 72(9). 717–736. 31 indexed citations

Vermeulen, Lee C., James M. Hoffman, Nilay D. Shah, et al.. (2015). Accuracy of annual prescription drug expenditure forecasts inAJHP. American Journal of Health-System Pharmacy. 72(19). 1642–1648. 7 indexed citations

10.

Dunnenberger, Henry M., Kristine R. Crews, James M. Hoffman, et al.. (2014). Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers. The Annual Review of Pharmacology and Toxicology. 55(1). 89–106. 345 indexed citations breakdown →

11.

Suda, Katie J., Lauri A. Hicks, Rebecca M. Roberts, Robert J. Hunkler, & Thomas H. Taylor. (2014). Trends and Seasonal Variation in Outpatient Antibiotic Prescription Rates in the United States, 2006 to 2010. Antimicrobial Agents and Chemotherapy. 58(5). 2763–2766. 131 indexed citations

12.

Suda, Katie J., et al.. (2013). Outpatient influenza antiviral prescription trends with influenza-like illness in the USA, 2008–2010. International Journal of Antimicrobial Agents. 43(3). 279–283. 3 indexed citations

13.

Hoffman, James M., Edward Li, Fred Doloresco, et al.. (2012). Projecting future drug expenditures—2012. American Journal of Health-System Pharmacy. 69(5). 405–421. 60 indexed citations

14.

Suda, Katie J., et al.. (2012). A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. Journal of Antimicrobial Chemotherapy. 68(3). 715–718. 126 indexed citations

15.

Doloresco, Fred, Glen T. Schumock, Lee C. Vermeulen, et al.. (2011). Projecting future drug expenditures—2011. American Journal of Health-System Pharmacy. 68(10). 921–932. 33 indexed citations

16.

Hoffman, James M., Nilay D. Shah, Lee C. Vermeulen, et al.. (2009). Projecting future drug expenditures—2009. American Journal of Health-System Pharmacy. 66(3). 237–257. 31 indexed citations

17.

Hoffman, James M., Nilay D. Shah, Lee C. Vermeulen, et al.. (2008). Projecting future drug expenditures—2008. American Journal of Health-System Pharmacy. 65(3). 234–253. 29 indexed citations

18.

Hoffman, James M., et al.. (2007). Projecting future drug expenditures—2007. American Journal of Health-System Pharmacy. 64(3). 298–314. 24 indexed citations

19.

Hoffman, James M., et al.. (2005). Projecting future drug expenditures—2005. American Journal of Health-System Pharmacy. 62(2). 149–167. 32 indexed citations

20.

Hoffman, James M., et al.. (2004). Projecting future drug expenditures—2004. American Journal of Health-System Pharmacy. 61(2). 145–158. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact